Analysis of tracer transit in rat brain after carotid artery and femoral vein administrations using linear system theory.
Determination of tissue perfusion rates by MRI bolus tracking methods relies on the central volume principle which states that tissue blood flow is given by the tissue blood volume divided by the mean tracer transit time (MTT). Accurate determination of the MTT requires knowledge of the arterial input function which in MRI experiments is usually not known, especially when using small animals. The problem of unknown arterial input can be circumvented in animal experiments by directly injecting the contrast agent into a feeding artery of the tissue of interest. In the present article the passage of magnetite nanoparticles through the rat cerebral cortex is analyzed after injection into the internal carotid artery. The results are discussed in the framework of linear system theory using a one-compartment model for brain tissue and by using the well characterized gamma-variate function to describe the tissue concentration profile of the contrast agent. The results obtained from the intra-arterial tracer administration experiments are then compared with the commonly used intra-venous injection of the contrast agent in order to estimate the contribution of the peripheral circulation to the MTT values in the latter case. The experiments were analyzed using a two-compartment model and the gamma-variate function. As an application perfusion rates in normal and ischemic cerebral cortex of hypertensive rats were estimated in a model of focal cerebral ischemia. The results indicate that peripheral circulation has a significant influence on the MTT values and thus on the perfusion rates, which cannot be neglected.
Rudin
M
M
Core Technology Area, Novartis Pharma Ltd., Basel, Switzerland. Markus.Rudin@pharma.novartis.com
Beckmann
N
N
Sauter
A
A
D000818:Animals; D002343:Carotid Artery, Internal; D002540:Cerebral Cortex / Q000378:metabolism*; D003287:Contrast Media / Q000008:administration & dosage / Q000378:metabolism*; D005263:Femoral Artery; D052203:Ferrosoferric Oxide; D007501:Iron / Q000008:administration & dosage / Q000378:metabolism* / Q000493:pharmacokinetics; D008279:Magnetic Resonance Imaging / Q000379:methods; D008297:Male; D008962:Models, Theoretical; D010087:Oxides / Q000008:administration & dosage / Q000378:metabolism* / Q000493:pharmacokinetics; D051381:Rats; D011918:Rats, Inbred SHR
D003287:Contrast Media; D010087:Oxides; D007501:Iron; D052203:Ferrosoferric Oxide